Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Baxter
Medtronic
McKesson
Express Scripts

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

TROVAN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Trovan, and what generic alternatives are available?

Trovan is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-two drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.

Summary for TROVAN
Drug patent expirations by year for TROVAN
Synonyms for TROVAN
(1|A,5|A,6|A)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid methanesulfonate
(1alpha,5alpha,6alpha)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid methanesulfonate
(1alpha,5alpha,6alpha)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
(1R,5S,6s)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5-oxo-5,8-dihydro-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hexan-6-aminium methanesulfonate
0P1LKO80WN
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, (1-alpha,5-alpha,6-alpha)-
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, (1alpha,5alpha,6alpha)-, monomethanesulfonate
1,8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, (1alpha,5alpha,6alpha)-, monomethanesulfonate
1,8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-(1alpha,5alpha,6alpha)-, monomethanesulfonate
1,8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, (1alpha,5alpha,6alpha)-
146836-84-2
147059-72-1
147059-75-4
7-((1R,5S,6s)-6-Amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, monomethanesulfonate
7-((1R,5S,6S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-((1R,5S)-6-Amino-3-aza-bicyclo[3.1.0]hex-3-yl)-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
7-((1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-[(1?,5?,6?)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid mesylate
7-[(1|A,5|A,6|A)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Methanesulfonate
7-[(1alpha,5alpha)-6beta-Amino-3-azabicyclo[3.1.0]hexane-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate
7-[(1r,5s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-[(1r,5s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate(1:1)
7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; methanesulfonic acid
9F388J00UK
AC1L1Y44
AC1L1Y47
AC1Q4NG5
AC1Q6WCM
AKOS000277872
AKOS000280396
AKOS015909896
AKOS015914051
AN-1195
API0004697
API0008271
BCP12644
C-22002
C07664
C20H15F3N4O3
C20H15F3N4O3.CH4O3S
CAS-147059-75-4
CC-35528
CCG-221411
CHEBI:77568
CHEBI:9763
CHEMBL1200779
CHEMBL428
CP 99219
CP 99219 mesylate
CP 99219-27
CP-99,219
CP-99,219-27
CP-99219
CP-99219-27
CP-9921927
CP99219
CTK4C5244
D02123
D08654
DB00685
DSSTox_CID_25701
DSSTox_GSID_45701
DSSTox_RID_81073
DTXSID0041145
DTXSID0045701
DYNZICQDCVYXFW-AHZSKCOESA-N
DYNZICQDCVYXFW-GIPYJWDTSA-N
EX-A897
Fluorinated quinolone
FT-0601549
FT-0675705
HMS3260E16
I14-31851
I14-44539
J-008308
J-690188
LS-95890
LS-95905
MFCD00913361
MolPort-005-935-608
NCGC00064532-02
NCGC00260792-01
NCGC00263538-01
SC-47970
SCHEMBL34465
SCHEMBL34466
SCHEMBL40874
SCHEMBL40875
SCHEMBL9177464
Tox21_110980
Tox21_110980_1
Tox21_500107
TR6
Trovafloxacin
Trovafloxacin (INN)
Trovafloxacin [INN]
Trovafloxacin mesilate
Trovafloxacin mesylate
Trovafloxacin mesylate (USAN)
Trovafloxacin mesylate [USAN]
Trovafloxacin mesylate, >98% (HPLC)
Trovafloxacin methanesulfonate
trovafloxacin monomesylate
Trovafloxacin monomethanesulfonate
Trovafloxacin sulfate
trovafloxacine
trovafloxacino
trovafloxacinum
Trovan (oral)
Trovan (TN)
Turvel
TVFX
UNII-0P1LKO80WN
UNII-9F388J00UK
WVPSKSLAZQPAKQ-CDMJZVDBSA-N
X2013
ZINC100030989
ZINC12503149
ZINC147175374

US Patents and Regulatory Information for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-002 Dec 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-001 Dec 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer TROVAN/ZITHROMAX COMPLIANCE PAK azithromycin dihydrate; trovafloxacin mesylate FOR SUSPENSION, TABLET;ORAL 050762-001 Dec 18, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Express Scripts
Mallinckrodt
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.